Froedtert Hospital Testing Remdesivir
10 patients infected with COVID-19 will be treated with drug as part of nationwide study.
Three months after the first case of COVID-19 was diagnosed in Wisconsin, potential treatments are underway.
The most recent is an antiviral drug made by the pharmaceutical company Gilead Sciences, which is donating 1.5 million vials of the drug remdesivir for emergency use in critically ill patients.
Ten patients infected with COVID-19 will be treated with the drug at Froedtert Hospital in Milwaukee as part of a nationwide study of its effectiveness.
“I’m very excited we will have access to this medication for our most severely affected patients,” said the principal investigator of the study, Mary Beth Graham, medical director of Infection Prevention & Control at Froedtert Hospital.
“In some other ways, I’m hoping we don’t have to use it because I don’t want anybody to be in that situation where they are that ill from COVID that we would use it,” Graham added.
Remdesivir is currently the only antiviral drug available for COVID-19 patients, Graham said. But it’s not new. It was also tried as a potential treatment for hepatitis C and Ebola but was unsuccessful.
Distribution is controlled by the federal government under emergency use authorization from the U.S. Food and Drug Administration.
Both research hospitals are currently using another method to help treat COVID-19 patients: convalescent plasma, donated by those who have recovered from the new coronavirus.
UW Health has injected 15 patients with the special plasma so far. The principal investigator for that study is William Hartman, an assistant professor of anesthesiology at the University of Wisconsin-Madison School of Medicine and Public Health.
Several of the 15 patients have been taken off ventilators, although a UW spokesperson cautions they can’t attribute the improved outcomes to convalescent plasma, and added that outcomes have been better when patients are treated before needing to be admitted to the intensive care unit.
Froedtert had treated 10 patients with convalescent plasma as of Monday afternoon and Graham said they are “cautiously optimistic.”
By using plasma from recovered coronavirus patients, investigators hope to augment a sick person’s immune system. Donors in Dane County have included a 75-year-old man who beat COVID-19 after suffering only mild symptoms.
Graham said it’s “amazing” what scientists now know compared to just eight weeks ago. But she recognizes people are anxious for science to work as fast as possible in finding potential treatments and a vaccine for the coronavirus.
“People are like, ‘Why is it taking so long?’ If you look back at other diseases, this has been phenomenally rapid, the amount of information we have,” she said.
Listen to the WPR report here.
Remdesivir Being Used To Treat Some COVID-19 Patients In Wisconsin was originally published by Wisconsin Public Radio.
- MKE County: COVID-19 Declining to Summer Levels - Graham Kilmer - Feb 26th, 2021
- State Launches Vaccine Provider Map - Graham Kilmer - Feb 26th, 2021
- WI Daily: 656 New COVID-19 Cases - Urban Milwaukee - Feb 26th, 2021
- Supervisor Martin Calls on State Officials to Prioritize District 7 in Vaccination Effort - Sup. Felesia Martin - Feb 26th, 2021
- WI Daily: 840 New COVID-19 Cases - Urban Milwaukee - Feb 25th, 2021
- Evers Signs Bill on Unemployment System - Laurel White - Feb 25th, 2021
- DHS Announces Groups Eligible for COVID-19 Vaccine on March 1 - Wisconsin Department of Health Services - Feb 25th, 2021
- Milwaukee Health Department Adjusts Testing Hours at American Family Field - City of Milwaukee Health Department - Feb 25th, 2021
- WI Daily: 747 New COVID-19 Cases - Urban Milwaukee - Feb 24th, 2021
- State Creates 4 Community Vaccine Clinics - Megan Hart - Feb 24th, 2021
Read more about Coronavirus Pandemic here